Arrowhead Pharmaceuticals, Inc. (ARWR)
79.56
+0.67
(+0.85%)
USD |
NASDAQ |
Jun 29, 14:25
Arrowhead Pharmaceuticals Cash from Investing (TTM) : -704.02M for March 31, 2026
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -704.02M |
| December 31, 2025 | -229.95M |
| September 30, 2025 | -129.29M |
| June 30, 2025 | -424.84M |
| March 31, 2025 | -559.28M |
| December 31, 2024 | -408.00M |
| September 30, 2024 | -420.07M |
| June 30, 2024 | -166.64M |
| March 31, 2024 | -183.49M |
| December 31, 2023 | 49.38M |
| September 30, 2023 | -96.16M |
| June 30, 2023 | -90.22M |
| March 31, 2023 | -19.04M |
| December 31, 2022 | -52.73M |
| September 30, 2022 | -5.417M |
| June 30, 2022 | -160.11M |
| March 31, 2022 | -240.93M |
| December 31, 2021 | -205.22M |
| September 30, 2021 | -141.68M |
| June 30, 2021 | -89.33M |
| March 31, 2021 | -75.82M |
| December 31, 2020 | -219.90M |
| September 30, 2020 | -240.78M |
| June 30, 2020 | -158.05M |
| March 31, 2020 | -137.62M |
| Date | Value |
|---|---|
| December 31, 2019 | 29.29M |
| September 30, 2019 | -47.75M |
| June 30, 2019 | -61.33M |
| March 31, 2019 | -104.58M |
| December 31, 2018 | -76.55M |
| September 30, 2018 | -7.435M |
| June 30, 2018 | -14.90M |
| March 31, 2018 | 1.028M |
| December 31, 2017 | -41.99M |
| September 30, 2017 | -48.64M |
| June 30, 2017 | -46.14M |
| March 31, 2017 | -23.75M |
| December 31, 2016 | 5.558M |
| September 30, 2016 | 13.45M |
| June 30, 2016 | 21.01M |
| March 31, 2016 | 15.52M |
| December 31, 2015 | 21.21M |
| September 30, 2015 | 14.12M |
| June 30, 2015 | 12.82M |
| March 31, 2015 | 9.780M |
| December 31, 2014 | -25.84M |
| September 30, 2014 | -36.48M |
| June 30, 2014 | -47.55M |
| March 31, 2014 | -52.74M |
| December 31, 2013 | -24.78M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Twist Bioscience Corp. | -44.44M |
| Revolution Medicines, Inc. | 306.62M |
| ImmunityBio, Inc. | -185.58M |
| Vera Therapeutics, Inc. | 41.15M |
| Erasca, Inc. | -177.67M |